Efficacy Of Coenzyme Q10 In Migraine Prophylaxis: A Randomized Controlled Trial
Notes for this study:
||# of days with nausea/vomitting. Change. Mean and SD. Placebo: 0.8 (2.2). Intervention: 0.9 (1.8)
|Number of Subjects
In a randomized, double0blind, placebo-controlled trial, 42 migraine patients were allocated to 300 mg of coenzyme q10 or placebo daily for 4 months.
The primary outcome was the frequency of migraine attacks, and there was a reduction in the number of attacks, which was statistically significant compared with placebo. There was also a statistically significant reduction in the number of days of nausea/vomiting, and a nonsignificant reduction in migraine severity, and duration of migraines.